These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32246337)

  • 1. Resazurin-Based Assay to Evaluate Cell Viability After Quantum Dot Interaction.
    Pereira MIA; Monteiro CAP; de Oliveira WF; Santos BS; Fontes A; Cabral Filho PE
    Methods Mol Biol; 2020; 2135():213-221. PubMed ID: 32246337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Formation of Resorufin and Resazurin with Β-Cyclodextrins: Can Cyclodextrins Interfere with a Resazurin Cell Viability Assay?
    Csepregi R; Lemli B; Kunsági-Máté S; Szente L; Kőszegi T; Németi B; Poór M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resazurin Live Cell Assay: Setup and Fine-Tuning for Reliable Cytotoxicity Results.
    Rodríguez-Corrales JÁ; Josan JS
    Methods Mol Biol; 2017; 1647():207-219. PubMed ID: 28809005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin.
    Präbst K; Engelhardt H; Ringgeler S; Hübner H
    Methods Mol Biol; 2017; 1601():1-17. PubMed ID: 28470513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved resazurin-based cytotoxicity assay for hepatic cells.
    McMillian MK; Li L; Parker JB; Patel L; Zhong Z; Gunnett JW; Powers WJ; Johnson MD
    Cell Biol Toxicol; 2002; 18(3):157-73. PubMed ID: 12083422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays.
    Rampersad SN
    Sensors (Basel); 2012; 12(9):12347-60. PubMed ID: 23112716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays.
    Walzl A; Unger C; Kramer N; Unterleuthner D; Scherzer M; Hengstschläger M; Schwanzer-Pfeiffer D; Dolznig H
    J Biomol Screen; 2014 Aug; 19(7):1047-59. PubMed ID: 24758920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the dose-depth distribution of proton beam using resazurin assay in vitro and diode laser-induced fluorescence detection.
    Kim MJ; Pal S; Tak YK; Lee KH; Yang TK; Lee SJ; Song JM
    Anal Chim Acta; 2007 Jun; 593(2):214-23. PubMed ID: 17543610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Metabolic Viability and Cell Mass Using a Tandem Resazurin/Sulforhodamine B Assay.
    Silva FSG; Starostina IG; Ivanova VV; Rizvanov AA; Oliveira PJ; Pereira SP
    Curr Protoc Toxicol; 2016 May; 68():2.24.1-2.24.15. PubMed ID: 27145111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status.
    Vieira-da-Silva B; Castanho MARB
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of a resazurin-based assay for the evaluation of metabolic activity in oral squamous carcinoma and glioblastoma cells.
    Rezende N; Ceron Jayme C; Brassesco MS; Claudio Tedesco A; de Oliveira HF
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():371-374. PubMed ID: 31063861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific interaction of carbon nanotubes with the resazurin assay reagent: impact on in vitro assessment of nanoparticle cytotoxicity.
    Breznan D; Das D; MacKinnon-Roy C; Simard B; Kumarathasan P; Vincent R
    Toxicol In Vitro; 2015 Feb; 29(1):142-7. PubMed ID: 25283091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveats to the use of MTT, neutral red, Hoechst and Resazurin to measure silver nanoparticle cytotoxicity.
    Mello DF; Trevisan R; Rivera N; Geitner NK; Di Giulio RT; Wiesner MR; Hsu-Kim H; Meyer JN
    Chem Biol Interact; 2020 Jan; 315():108868. PubMed ID: 31669321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reduction of resazurin; location within the cell for cytotoxicity assays.
    Chen JL; Steele TWJ; Stuckey DC
    Biotechnol Bioeng; 2018 Feb; 115(2):351-358. PubMed ID: 29030966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
    van Tonder A; Joubert AM; Cromarty AD
    BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fast Resazurin-based live viability assay is equivalent to the MTT-test in the KeratinoSens assay.
    Emter R; Natsch A
    Toxicol In Vitro; 2015 Jun; 29(4):688-93. PubMed ID: 25687527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells.
    Xu M; McCanna DJ; Sivak JG
    J Pharmacol Toxicol Methods; 2015; 71():1-7. PubMed ID: 25464019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.
    Umubyeyi AN; Martin A; Zissis G; Struelens M; Karita E; Portaels F
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):808-11. PubMed ID: 16848345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three different cell viability assays for evaluation of vanadyl sulphate cytotoxicity in a Chinese hamster ovary K1 cell line.
    Zwolak I
    Toxicol Ind Health; 2016 Jun; 32(6):1013-25. PubMed ID: 25107459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of resazurin-based viability staining for quantification of microbial biofilms.
    Van den Driessche F; Rigole P; Brackman G; Coenye T
    J Microbiol Methods; 2014 Mar; 98():31-4. PubMed ID: 24365109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.